Skip to main navigation
Oric Logo Oric Logo OricPharma logo
  • About
    • Overview
    • Leadership Team
    • Board of Directors
    • Founders
    • Contact
  • Pipeline
    • Overview
    • Rinzimetostat (ORIC-944)
    • Enozertinib (ORIC-114)
    • Publications
  • Patients
    • Overview
    • Clinical Trials
  • Investors & News
    • Overview
    • Press Releases
    • Events & Presentations
    • Stock Information
    • Analyst Coverage
    • Corporate Governance
    • SEC Filings
    • Quarterly Results
    • Investor FAQs
    • Contact IR
  • Careers
    • Overview
    • Culture & Values
    • Benefits
    • Current Openings
CONTACT US
info@oricpharma.com
(650) 388-5600
 
Scientist in lab
  • Documents & Charters
  • Board of Directors
  • Leadership Team
  • Committee Composition

Committee Composition

Committee Composition

Audit Committee Compensation Committee Nominating and Corporate Governance Committee
Richard Heyman Compensation Committee Nominating and Corporate Governance Committee
Mardi C. Dier Audit Committee Nominating and Corporate Governance Committee
Lori Kunkel Compensation Committee
Steve Hoerter Audit Committee Compensation Committee
Angie You Audit Committee Nominating and Corporate Governance Committee
= Chairperson = Member = Chairman of the Board
Print PRINT
Email Page EMAIL PAGE
Contact IR Contact IR
RSS RSS
Email Alerts Email Alerts
Contact
info@oricpharma.com
(650) 388-5600
 
  • Home
  • Pipeline
  • Investors & News
  • Privacy Policy
  • About
  • Patients
  • Careers
  • Terms of Use
©2026 ORIC Pharmaceuticals, Inc. All rights reserved.
ORIC and the stylized ORIC mark are registered trademarks of ORIC Pharmaceuticals, Inc.